Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on May 22, 2025

Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China

Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China

Achieved statistically significant ≥1-stage fibrosis regression at Week 52 vs. placebo (52.85% vs. 29.84%, P=0.0002). Demonstrated favorable safety and tolerability profile: 4.88% serious adverse events vs. 6.45% for placebo; zero discontinuations due to …

PESG Research Report: A Review of Silexion Therapeutics' Innovative KRAS-Driven Cancer Treatment

PESG Research Report: A Review of Silexion Therapeutics' Innovative KRAS-Driven Cancer Treatment

New York, May 22, 2025 (GLOBE NEWSWIRE) -- PESG Research today announced the release of a report examining Silexion Therapeutics, an innovative biotechnology company developing unique RNA interference (RNAi) therapies targeting KRAS-driven cancers. The …

Houston Emerges as Global Center for Brain Health Innovation

Houston Emerges as Global Center for Brain Health Innovation

HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Protecting and enriching human brain health and performance may be one of the most important economic strategies that businesses and governments pursue as they seek to strengthen workforces, mitigate the surging …

Endurance Bio Inc. Announces Selection of T-168 for Neuro-SysMed’s SLEIPNIR Platform Trial in Parkinson’s Disease

Endurance Bio Inc. Announces Selection of T-168 for Neuro-SysMed’s SLEIPNIR Platform Trial in Parkinson’s Disease

SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Endurance Bio Inc., a clinical-stage biotechnology company developing therapies for neurodegenerative and metabolic diseases, today announced that its compound, T-168, has been selected for testing on …

Mardy Gould Appointed Managing Director at EHP, Leading Expansion of Innovative Employee Benefit Solutions Nationwide

Mardy Gould Appointed Managing Director at EHP, Leading Expansion of Innovative Employee Benefit Solutions Nationwide

Mardy Gould to drive EHP Inc.'s national growth, delivering innovative, tax-advantaged employee benefits solutions to employers nationwide. JACKSONVILLE, FL, UNITED STATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- EHP Inc., a premier provider of comprehensive …

Newly Formed National Alliance Aims to Help Cities and States Combat Opioid Crisis and Improve Public Health Outcomes

Newly Formed National Alliance Aims to Help Cities and States Combat Opioid Crisis and Improve Public Health Outcomes

Milwaukee, Wis., May 22, 2025 (GLOBE NEWSWIRE) -- In a timely effort to address the nation’s opioid epidemic, CMRignite, one of the nation’s leading cause marketing agencies, has launched a new national recovery alliance composed of trusted messengers, …

Celebrating 10 Years of National Deafblind Awareness Month in Canada

Celebrating 10 Years of National Deafblind Awareness Month in Canada

Newmarket, Ontario, Canada, May 22, 2025 (GLOBE NEWSWIRE) -- June 2025 marks a significant milestone—10 years since the Senate of Canada officially proclaimed June as National Deafblind Awareness Month. This anniversary is a powerful opportunity to …

Arcutis’ ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older

Arcutis’ ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older

Once-daily ZORYVE foam provides powerful clearance and rapid itch relief from head to toe with no limitation on duration of use More than half of the nearly 9 million people in the United States with plaque psoriasis experience scalp involvement Healthcare …

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes

TEL AVIV, Israel, May 22, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it is increasing the maximum tender amount of its tender offer previously announced on May 19, 2025 from $2.0 billion …

CareSource and Three Square Food Bank unite to tackle hunger in Southern Nevada

CareSource and Three Square Food Bank unite to tackle hunger in Southern Nevada

LAS VEGAS, May 22, 2025 (GLOBE NEWSWIRE) -- Today, CareSource Nevada, a nonprofit managed care organization recently selected to implement Nevada’s Medicaid Managed Care Program, awarded Three Square Food Bank a $10,000 donation and a Heart of the …

Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting

Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting

WARREN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that it will provide several updates to stockholders in advance of the Company’s upcoming Annual Meeting of Stockholders …

Global High-Throughput Screening Market Poised for Strong Growth, Hitting $39.2 Billion by 2029

Global High-Throughput Screening Market Poised for Strong Growth, Hitting $39.2 Billion by 2029

Boston, May 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “High-Throughput Screening: Technologies and Global Markets” is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029 at a compound annual …

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

CARMEL, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults …

Global Foley Catheters Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight

Global Foley Catheters Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight

New York, USA, May 22, 2025 (GLOBE NEWSWIRE) -- Global Foley Catheters Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight The growing demand for Foley catheters is driven by several important factors. Firstly, the …

Hypofibrinogenemia Market Set to Grow as New Treatments Emerge During the Forecast Period (2025–2034) | DelveInsight

Hypofibrinogenemia Market Set to Grow as New Treatments Emerge During the Forecast Period (2025–2034) | DelveInsight

New York, USA, May 22, 2025 (GLOBE NEWSWIRE) -- Hypofibrinogenemia Market Set to Grow as New Treatments Emerge During the Forecast Period (2025–2034) | DelveInsight  DelveInsight projects a promising growth trajectory for the hypofibrinogenemia market …

Press release: Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders

Press release: Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders

Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders Ghent, Belgium, 22 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant …

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced that it has received a ruling to expedite a …

Nisa Foundation’s Brand New Transition House Offers Greater Support and Culturally-Responsive Care for Women and Children Fleeing Violence

Nisa Foundation’s Brand New Transition House Offers Greater Support and Culturally-Responsive Care for Women and Children Fleeing Violence

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- In partnership with BC Housing, Nisa Foundation is proud to announce the expansion of Nisa Homes Vancouver, with a brand new location now operating as a 24/7 transition house with double the …

Bio Usawa and Pacific Environmental Technologies Announce Landmark Partnership to Develop and Deploy Modular cGMP Biomanufacturing Units for Africa

Bio Usawa and Pacific Environmental Technologies Announce Landmark Partnership to Develop and Deploy Modular cGMP Biomanufacturing Units for Africa

SAN FRANCISCO and KIGALI, Rwanda, May 22, 2025 (GLOBE NEWSWIRE) -- Bio Usawa, Inc., a biopharmaceutical company based in San Francisco, Kigali, and Nairobi, committed to expanding access to life-saving biologics in Africa and underserved regions, today …

Legend Senior Living’s Workplace Culture Earns Seventh Great Place to Work® Certification

Legend Senior Living’s Workplace Culture Earns Seventh Great Place to Work® Certification

WICHITA, Kan., May 22, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living® has earned its seventh consecutive Great Place to Work® certification, a distinction based on results from an annual, anonymous employee survey conducted by the independent research firm …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service